Form 4 for MRK Merck & Co.
Accepted 2026-05-05 13:47:30 ET · period of report 2026-05-02 · accession 0000310158-26-000113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-05 13:47 | 2026-05-02 | MRK | Maraldo David R. | EVP, Pres. MMD | M - OptEx | $112.16 | +552 | 18.4K | +3% | +$61.9K |
| D | 2026-05-05 13:47 | 2026-05-02 | MRK | Maraldo David R. | EVP, Pres. MMD | F - Tax | $112.16 | -159 | 18.2K | -0.9% | -$17.8K |
| D | 2026-05-05 13:47 | 2026-05-02 | MRK | Maraldo David R. | EVP, Pres. MMD | M - OptEx | $0.00 | -552 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-02 | M | A | 552 | $112.16 | 18,371.43 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-02 | F | D | 159 | $112.16 | 18,212.43 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-05-02 | M | D | 552 | $0.00 | 0 | D | — · 2024-05-02 to 2026-05-02 | 552 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F2) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025, and 5/2/2026. |